Delivery Order SPE2DR25D3301-SPE2DR26F19UM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $146,369.15 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML meningococcal vaccine, with an ultimate completion date of November 26, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $8,177.53 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal vaccine. The contract is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive procurement with no set-aside designation and falls under...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Menveo vaccine on December 9, 2025, with a ceiling value of $70,647.06 and an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $2,927.28 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo (meningococcal vaccine) in a single-vial format containing antigens A, C, Y, W-135 at 0.5 mL concentration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 6, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $43,115.10 delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside award executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $4,383.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menveo 1 Vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. The contract has an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded. As a...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19UMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Menveovax (MENVEO) meningococcal vaccine (1 vial, formulation A-C-Y-W-135-DIP, 0.5 mL) with a ceiling value of $8,451.50. This competitive, non-set-aside award was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The delivery order carries firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this award represents a discrete purchase within AmerisourceBergen's broader federal pharmaceutical supply framework. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and established federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The MENVEO vaccine delivery under this order supports critical immunization requirements across the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 12/18/25 |